Pfizer’s Phase 2/3 ‘COVID Pill Study’ Reveals Potential Antiviral Treatment (PF-07321332) Under Investigation

Pfizer’s Phase 2/3 ‘COVID Pill Study’ Reveals Potential Antiviral Treatment (PF-07321332) Under Investigation

The race is on for the clinical development of the "COVID-19 pill," an orally administered antiviral medication for early treatment that primary care providers have screamed about for over 1.5 years now. While generic repurposed drugs show mixed results, the overall ledger of ivermectin studies weighs in the positive zone. Groups such as the National Institute of Allergy and Infectious Diseases (NIAID) closely monitor the investigational pharmaceutical products working their way down the pipeline. At least in America and much of the world, a vaccine-centric strategy pulled overwhelming public subsidy, but the challenge is that the vaccines don't stop transmission. That's become apparent with the delta variant, where the number of breakthrough infections leading to hospitalization now mounts in heavily vaccinated nations like Israel. Pfizer recently was active on Facebook, essentially advertising their orally administered, potent protease inhibitor, evidencing antiviral activity against SARS-CoV-2. As it turns out, these studies focus on patients with more risk and include a combined treatment with Ritonavir. The goal: inhibit disease progression and care for the patient at home.

...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee